Skip to content
Broker news. Connected. RSS feed
FXBROKERS

A clearer view of the broker industry.

ClearToken and Consensys plan round-the-clock wholesale settlement with distinct UK regulatory approvals

The partnership targets continuous delivery-versus-payment settlement of tokenised securities, but ClearToken's securities depository, payments and CCP permissions are not interchangeable.

ClearToken and blockchain infrastructure company Consensys have agreed to cooperate on around-the-clock wholesale settlement for banks, asset managers and brokers. The 8 October partnership announcement focuses on tokenised securities and their cash legs: the two sides want institutional users to transfer assets and settlement money continuously, with technology that can connect across networks. This is a development and distribution agreement, not a notice that a universal live clearing utility has been launched for every broker.[1][2]

The announcement separates two kinds of finality that can be confused in digital-asset promotions. Cryptographic finality concerns whether transactions recorded to a particular ledger can be reversed or rewritten. Legal settlement finality concerns the binding and irrevocable transfer of ownership and payment under applicable law and a regulated system's rules. One does not automatically establish the other, particularly when an asset or its cash backing moves between institutions or jurisdictions.[1]

ClearToken CSD Limited has passed Gate 2 of the Bank of England's Digital Securities Sandbox, allowing specified digital-securities-depository activities within limits and conditions. ClearToken Depository Limited is a separate FCA-authorised payment institution. The proposed central counterparty, ClearToken CCP Limited, has applied to the Bank of England for CCP authorisation but had not obtained it in this announcement. Combining those entities under the ClearToken brand does not create a single licence authorising all contemplated clearing, payments and custody functions.[1]

What each partnership participant is authorised or planning to do

Consensys is being engaged for the technical part: scalable tokenisation, cross-network interoperability and institutional wallet connectivity. ClearToken's stated aim is delivery-versus-payment settlement for eligible securities against fiat currency, tokenised deposits or permitted stablecoins. The public material does not provide a list of bank counterparties already exchanging production collateral through this particular partnership, or an independently verified daily transaction volume. Those commercial claims should not be inferred from its technical architecture.[1]

A broker considering the service would need to know which legal entity holds an account, whether cash and securities can move simultaneously, how defaults and failed settlements are handled, and what happens when an underlying ledger is available but ordinary payment or securities-transfer systems are closed. Margining, capital and protection arrangements also depend on entity-specific approvals. A blockchain transaction receipt alone is not evidence that all those obligations have been discharged.[1]

At a glance01

What each partnership participant is authorised or planning to do

What each partnership participant is authorised or planning to do
Entity or functionDocumented October status
ClearToken CSD LimitedDigital Securities Sandbox Gate 2; conditional securities-depository activities
ClearToken Depository LimitedFCA-authorised payment institution
ClearToken CCP LimitedBank of England CCP application; authorisation not yet granted
ConsensysTechnology and interoperability partner
24/7 universal clearingStrategic objective; not verified as a completed multi-asset production rollout

The concrete October development is the ClearToken–Consensys partnership and the status of the participating regulated entities. Its attraction to brokers is the potential for lower settlement friction and continuous asset movement. Claims of universally available 24/7 regulated central clearing, however, would go beyond the authorisations and live-delivery evidence cited in the release.[1]

Follow the evidence

Sources & further reading

Report an error or submit an update